The Role of Stem Cells in Parkinson's Disease

Neurosurgery Clinics of North America

Volumn 18, Issue 1, 2007, Pages 129-142

  Gupta, Amitabh ^a   Dawson, Ted M ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; PRAMIPEXOLE; PROTEIN KINASE INHIBITOR; RASAGILINE; RILUZOLE; ROPINIROLE; TRANSFORMING GROWTH FACTOR BETA;

BLOOD BRAIN BARRIER; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DYSKINESIA; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE MUTATION; HEREDITY; HUMAN; LIMBIC SYSTEM; NEOCORTEX; NERVE DEGENERATION; NEURAL STEM CELL; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; TISSUE TRANSPLANTATION;

ANIMALS; BRAIN; HUMANS; MOTOR NEURONS; MYENTERIC PLEXUS; NEURONS, AFFERENT; PARKINSON DISEASE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33846613770     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2006.10.015     Document Type: Review

References (57)

1. Suchowersky O., Reich S., Perlmutter J., et al. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66 (2006) 968-975
2. Shimura H., Hattori N., Kubo S., et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25 (2000) 302-305
3. Zhang Y., Gao J., Chung K.K., et al. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA 97 (2000) 13354-13359
4. Ko H.S., Kim S.W., Sriram S.R., et al. Identification of far upstream element-binding protein-1 as an authentic Parkin substrate. J Biol Chem 281 (2006) 16193-16196
5. Ko H.S., von Coelln R., Sriram S.R., et al. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci 25 (2005) 7968-7978
6. Valente E.M., Abou-Sleiman P.M., Caputo V., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
7. Biskup S.M.D., Celsi F., Higashi S., et al. Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol 60 (2006) 557-569
8. West A.B., Moore D.J., Biskup S., et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 102 (2005) 16842-16847
9. Smith W.W., Pei Z., Jiang H., et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9 (2006) 1231-1233
10. Schapira A.H., Cooper J.M., Dexter D., et al. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1 (1989) 1269
11. Savitt J.M., Dawson V.L., and Dawson T.M. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116 (2006) 1744-1754
12. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 20 Suppl 11 (2005) S11-S16
13. Pahwa R., Factor S.A., Lyons K.E., et al. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66 (2006) 983-995
14. Diamond A., and Jankovic J. Treatment of advanced Parkinson's disease. Expert Rev Neurother 6 (2006) 1181-1197
15. Menza M., and Marsh L. Psychiatric issues in Parkinson's disease. A practical guide (2005), Taylor and Francis, New York
16. Suchowersky O., Gronseth G., Perlmutter J., et al. Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66 (2006) 976-982
17. Lindvall O., and Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 441 (2006) 1094-1096
18. Lindvall O., Kokaia Z., and Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 10 Suppl (2004) S42-S50
19. Piccini P., Brooks D.J., Bjorklund A., et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2 (1999) 1137-1140
20. Piccini P., Lindvall O., Bjorklund A., et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 48 (2000) 689-695
21. Freed C.R., Greene P.E., Breeze R.E., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344 (2001) 710-719
22. Hagell P., Piccini P., Bjorklund A., et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 5 (2002) 627-628
23. Olanow C.W., Goetz C.G., Kordower J.H., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54 (2003) 403-414
24. Shim J.W., Koh H.C., Chang M.Y., et al. Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL. J Neurosci 24 (2004) 843-852
25. Kawasaki H., Mizuseki K., Nishikawa S., et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28 (2000) 31-40
26. Chung S., Sonntag K.C., Andersson T., et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 16 (2002) 1829-1838
27. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
28. Kim T.E., Lee H.S., Lee Y.B., et al. Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell. Biochem Biophys Res Commun 305 (2003) 1040-1048
29. Yoshizaki T., Inaji M., Kouike H., et al. Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett 363 (2004) 33-37
30. Takagi Y., Takahashi J., Saiki H., et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115 (2005) 102-109
31. Park C.H., Minn Y.K., Lee J.Y., et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 92 (2005) 1265-1276
32. Perrier A.L., Tabar V., Barberi T., et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 101 (2004) 12543-12548
33. Wagner J., Akerud P., Castro D.S., et al. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat Biotechnol 17 (1999) 653-659
34. Carvey P.M., Ling Z.D., Sortwell C.E., et al. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol 171 (2001) 98-108
35. Storch A., Paul G., Csete M., et al. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 170 (2001) 317-325
36. Studer L., Csete M., Lee S.H., et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20 (2000) 7377-7383
37. Studer L., Tabar V., and McKay R.D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1 (1998) 290-295
38. Yan J., Studer L., and McKay R.D. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J Neurochem 76 (2001) 307-311
39. Liste I., Garcia-Garcia E., and Martinez-Serrano A. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. J Neurosci 24 (2004) 10786-10795
40. Burnstein R.M., Foltynie T., He X., et al. Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int J Biochem Cell Biol 36 (2004) 702-713
41. Kishi Y., Takahashi J., Koyanagi M., et al. Estrogen promotes differentiation and survival of dopaminergic neurons derived from human neural stem cells. J Neurosci Res 79 (2005) 279-286
42. Wang X., Lu Y., Zhang H., et al. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int J Dev Neurosci 22 (2004) 175-183
43. Wang K., Wang J.J., Wang Y., et al. Infusion of epidermal growth factor and basic fibroblast growth factor into the striatum of parkinsonian rats leads to in vitro proliferation and differentiation of adult neural progenitor cells. Neurosci Lett 364 (2004) 154-158
44. Dezawa M., Kanno H., Hoshino M., et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113 (2004) 1701-1710
45. Jiang Y., Henderson D., Blackstad M., et al. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci USA 100 Suppl 1 (2003) 11854-11860
46. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
47. Li Y., Chen J., Wang L., et al. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 316 (2001) 67-70
48. Medicetty S., Bledsoe A.R., Fahrenholtz C.B., et al. Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks. Exp Neurol 190 (2004) 32-41
49. Eslamboli A., Cummings R.M., Ridley R.M., et al. Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus). Exp Neurol 184 (2003) 536-548
50. Kordower J.H., Emborg M.E., Bloch J., et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290 (2000) 767-773
51. Kirik D., Rosenblad C., Bjorklund A., et al. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20 (2000) 4686-4700
52. Song H., Stevens C.F., and Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature 417 (2002) 39-44
53. Amit M., Carpenter M.K., Inokuma M.S., et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227 (2000) 271-278
54. Draper J.S., Smith K., Gokhale P., et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22 (2004) 53-54
55. Mukhida K., Baker K.A., Sadi D., et al. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. J Neurosci 21 (2001) 3521-3530
56. Winkler C., Kirik D., Bjorklund A., et al. Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Prog Brain Res 127 (2000) 233-265
57. Mendez I., Dagher A., Hong M., et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 96 (2002) 589-596